Abstract
A dimethoxy amide chalcone has been synthesized in a two-step reaction. First, an amine chalcone was synthesized by the reaction of 4′-aminoacetophenone and 2,5-dimethoxybenzaldehyde using 40% NaOH solution as a catalyst in ethanol, and then followed by amidation through the reaction of the formed chalcone and succinic anhydride. The structure of the target compound was established by FTIR, HR-MS, 1H- and 13C-NMR, and 2D-NMR spectral analysis.
1. Introduction
Diaryl-α,β-unsaturated ketones are the biogenic precursor in flavonoid biosynthesis [1] and are known as chalcones. Due to their wide spectrum of pharmacological properties, such as antioxidant [2], antihepatotoxic [3], neuroprotective [4], antibacterial [5,6,7,8], inhibitor of topoisomerase I [9], antimalarial [10,11], and anticancer [12], chalcones attract many researchers to develop efficient synthetic methods and to gain various structural variations of chalcones unavailable in nature. In general, chalcones are synthesized by Claisen-Schmidt condensation.
Previously we have reported the antimicrobial activity of a series of methoxy amino chalcones [13,14]. In order to enhance their efficacy by increasing their solubility and slow release, we converted the basic amino chalcones into amide derivatives through a reaction with succinic anhydride. Herein we report a new amide methoxy chalcone prepared from a methoxy amino chalcone and succinic anhydride.
2. Results
The title compound was synthesized in a two-step reaction. The first step was the synthesis of a methoxy amino chalcone (1) employing the Claisen-Schmidt reaction, then followed by the amidation of (1) through the reaction of (1) with succinic anhydride in ethanol using pyridine as a catalyst, as shown in Scheme 1.
Scheme 1.
Synthesis pathway of the target compound.
Firstly, the purity of the product was analyzed by determining its melting point and thin layer chromatography. The structure of the product was then characterized based on spectroscopic evidence and the results are displayed below. The product is assumed to exist in the E configuration, since the 1H-NMR spectrum of the olefinic protons showed a coupling constant of 15.7 Hz indicative of the E configuration. The structure of the title compound and its HMBC correlations is displayed in Figure 1, whereas the chemical shifts and its HMBC correlations is tabulated in Table 1. The complete spectra are attached in supplementary materials.
Figure 1.
Structure, numbering and HMBC correlations of the title compound.
Table 1.
1H, 13C chemical shifts and HMBC correlations of the title compound.
(E)-4-((3-(3-(2,5-Dimethoxyphenyl)acryloyl)phenyl)amino)-4-oxobutanoic acid (2): orange solid (266 mg; 75%), m.p. 188–190 °C, Rf = 0.61 (ethanol), HR-MS [M + H]+ calculated for C21H21NO6 384.1447, found 384.1446; IR (KBr, cm−1) 3448 (br, -OH carboxylic), 3340 (str, -NH- amide), 1720 (str, C=O aliphatic carboxylic acid), 1697 (str, C=O amide), 1639 (C=O conjugated), 1593 (str, C=C conjugated), and 1261 (Calkyl-O-Caryl); 1H-NMR (400 MHz, DMSO-d6) δ (ppm) 12.15 (s, 1H), 10.32 (s, 1H), 8.10 (d, J = 8.7 Hz, 2H), 7.97 (d, J = 15.7 Hz, 1H), 7.86 (d, J = 15.7 Hz, 1H), 7.73 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 2.3 Hz, 1H), 7.08–6.92 (m, 2H), 3.80 (s, 3H), 3.76 (s, 3H), 2.58 (t, J = 6.2 Hz, 2H), 2.50 (t, J = 6.0 Hz, 2H). 13C-NMR (101 MHz, DMSO-d6) δ (ppm) 188.05, 174.33, 171.35, 153.77, 153.16, 144.19, 138.06, 132.64, 130.46, 124.08, 122.36, 118.73, 118.57, 113.53, 112.93, 56.66, 56.22, 31.71, 29.13.
The analysis of the correlation spectrum (2D NMR; HMBC) is tabulated in the Table 1 below.
3. Materials and Methods
3.1. General
All reagents and solvents (E.Merck (Darmstadt, Germany) or Sigma Aldrich (St. Louis, MO, USA)) were used without further purification. Reaction progress was monitored by TLC on silica gel GF254 aluminum sheets (0.25 mm) using various developing system. Spots were detected under UV light (λ 254 nm). Melting point was measured by Thermo Scientific Fisher-Johns Melting Point Apparatus 220 VAC (Waltham, MA, USA) and uncorrected. FTIR spectrum was recorded in KBr pellet on FTIR spectrophotometer Shimadzu 84005 series (Kyoto, Japan). Mass spectrum was recorded on HR mass spectrometer Waters LCT Premier XE (Santa Clara, CA, USA). NMR spectrum (1H-, 13C-NMR, and HMBC) was recorded using JEOL 400 ECA spectrometer (Tokyo, Japan) with DMSO-d6 as solvent and internal standard.
3.2. Preparation of the Title Compound (2)
The amino methoxy chalcone (1) was synthesized according to the protocol as described previously [2]. The title compound was synthesized as followed: 1 mmol succinic anhydride was dissolved in 5 mL DCM, then three drops of pyridine was added. The mixture was stirred at 40 °C for 10 min. Then 1 mmol of chalcone (1) in 2 mL DCM was added drop-wise, stirred overnight at room temperature. The precipitate was then filtered off and re-crystallized from ethanol.
4. Conclusions
We have demonstrated the synthesis of a methoxy amide chalcone derivative through the Claisen-Schmidt reaction, followed by amidation.
Supplementary Materials
FTIR, HRMS, 1H-NMR, 13C-NMR, HMBC spectra of the synthesized compound are available online.
Supplementary File 1Supplementary File 2Supplementary File 3Supplementary File 4Acknowledgments
The study was funded by The Ministry of Research and Higher Education of Indonesia under PUPT research grant 2016.
Author Contributions
H.S. brought out the idea, managed the research and wrote the paper. K.U.H. and A.N.K. analyzed the spectral data. N.N.D.R. performed the synthesis, while N.N.T.P. corrected the draft. All the authors have read the draft.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Lin, M.; Zhou, Y.; Flavin, M.T.; Zhou, L.; Nie, W.; Chen, F. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg. Med. Chem. 2002, 10, 2795–2782. [Google Scholar] [CrossRef]
- Kim, B.T.; Chun, J.C.; Hwang, K.J. Synthesis of dihydroxylated chalcone derivatives with diverse substitution pattern and their radical scavenging ability toward DPPH free radicals. Bull. Korean Chem. Soc. 2008, 29, 1125–1130. [Google Scholar] [CrossRef]
- Khan, S.A.; Ahmed, B.; Alam, T. Synthesis and hepatotoxic activity of some new chalcones containing 1,4-dioxane ring system. Pak. J. Pharm. Sci. 2006, 19, 290–294. [Google Scholar] [PubMed]
- Jung, J.-C.; Jang, S.; Lee, Y.; Min, D.; Lim, E.; Jung, H.; Oh, M.; Oh, S.; Jumg, M. Efficient synthesis and neuroprotective effect of substituted 1,3-diphenyl-2-propen-1-ones. J. Med. Chem. 2008, 51, 4054–4058. [Google Scholar] [CrossRef] [PubMed]
- Prasad, Y.R.; Kumar, P.R.; Smiles, D.J.; Babu, P.A. QSAR studies on chalcone derivatives as antibacterial agents against Bacillus pumilis. Arkivoc 2008, 11, 266–276. [Google Scholar]
- Sharma, M.; Chaturvedi, V.; Manju, Y.K.; Bhatnagar, S.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur. J. Med. Chem. 2009, 44, 2081–2091. [Google Scholar] [CrossRef] [PubMed]
- Asiri, A.M.; Khan, S.A. Synthesis and anti-bacterial activities of a bis-chalcone derived from thiophene and its bis-cyclized products. Molecules 2011, 16, 523–531. [Google Scholar] [CrossRef] [PubMed]
- Sivakumar, P.M.; Seenivasan, S.P.; Kumar, V.; Doble, M. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg. Med. Chem. Lett. 2007, 17, 1695–1700. [Google Scholar] [CrossRef] [PubMed]
- Yoon, G.; Kang, B.Y.; Cheon, S.H. Topoisomerase I inhibition and cytotoxicity of lichochalcones A and E from Glycyrrhiza inflate. Arch. Pharm. Res. 2007, 30, 313–316. [Google Scholar] [CrossRef] [PubMed]
- Dave, S.S.; Ghatole, A.M.; Rahatgaonkar, A.M.; Chorghade, M.S.; Chauhan, P.M.S.; Srivastava, K. Experimental and computational evaluation of new quinolinyl chalcones as potent antiplasmodial agents. Indian J. Chem. 2009, 48, 1780–1793. [Google Scholar]
- Suwito, H.; Pudjiastuti, P.; Fanani, M.Z.; Kimata-Ariga, Y.; Katahira, R.; Kawakami, T.; Fujiwara, T.; Hase, T.; Sirat, H.M.; Puspaningsih, N.N.T. Design and synthesis of chalcone derivatives as inhibitors of the ferredoxin—Ferredoxin-NADP+ reductase interaction of plasmodium falciparum: Pursuing new antimalarial agents. Molecules 2014, 19, 21473–21488. [Google Scholar] [CrossRef] [PubMed]
- Ferrer, R.; Lobo, G.; Gamboa, N.; Rodrigues, J.; Abramjuk, C.; Jung, K.; Lein, M.; Charris, J.E. Synthesis of [(7-chaloroquinolin-4-yl)amino]chalcones: Potential antimalarial and anticancer agents. Sci. Pharm. 2009, 77, 725–741. [Google Scholar]
- Suwito, H.; Jumina; Mustofa; Ni′matuzahroh; Puspaningsih, N.N.T. Anticancer and antimicrobial activity of methoxy amino chalcone derivatives. Der Pharma Chem. 2015, 7, 89–94. [Google Scholar]
- Suwito, H.; Kristanti, A.N.; Hayati, S.; Dewi, S.R.; Amalina, I.; Puspaningsih, N.N.T. Antimicrobial activities and in silico analysis of methoxy amino chalcone derivatives. Procedia Chem. 2016, 18, 103–111. [Google Scholar] [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).